Pick the relation: C = C₀·e−kt, LD = Vd·C/(S·F), maintenance rate = CL·Css/(S·F), τ = ln(Cpeak/Ctrough)/k.
For kidney function, estimate CrCl with Cockcroft–Gault first, then scale the dose or the interval.
Check the result: levels fall by half every half-life, and steady state takes about five half-lives.
2Practice problems
1.PharmacologyMedium
Ipratropium is a bronchodilator used in COPD. How does it work?
AIt stimulates beta-2 adrenergic receptors in the airways
BIt reduces inflammation like a corticosteroid
CIt blocks muscarinic receptors in airway smooth muscle
DIt blocks leukotriene receptors
2.PharmacologyHard
A woman has received a high-dose oxytocin infusion with large volumes of hypotonic fluid for many hours. She now has a headache, confusion and a low serum sodium. What is the most likely cause?
ANormal tiredness after a long labour
BExcessive salt in the infusion fluid
CWater intoxication from the antidiuretic effect of oxytocin
DAn allergic reaction to oxytocin causing brain swelling
3.Dosage calculationsMedium
A patient weighs 60 kg. The prescribed dose is 30 mg/kg per day, given in 3 equal doses. How many milligrams D are given per dose?
60 kg30 mg/kg/day3× per day
D = mg
4.Dosage calculationsHard
A patient is 156 cm tall and weighs 45 kg. The prescription is 250 mg/m². Using the Mosteller formula BSA = √(height (cm) × weight (kg)/3600), find the dose D in mg.
156 cm45 kg250 mg/m²
D = mg
5.Clinical pharmacokineticsMedium
Practice exercise (made-up values, not clinical guidance). A 63 kg patient receives a theophylline infusion. The clearance is 0.03 L/kg/h. What infusion rate R in mg/h gives a steady-state level of 12 mg/L?
63 kgCL = 0.03 L/kg/hCss = 12 mg/L
R = mg/h
6.Clinical pharmacokineticsHard
Practice exercise (made-up values, not clinical guidance). A patient's tobramycin half-life is 2.5 h. The target is a peak of 8 mg/L and a trough of 0.5 mg/L. Assuming rapid IV doses and first-order elimination, what dosing interval τ lets the level fall from the peak to the trough? Round to one decimal place.
t½ = 2.5 hCpeak = 8 mg/LCtrough = 0.5 mg/L
τ = h
3Solutions
1.Pharmacology
Answer: C · It blocks muscarinic receptors in airway smooth muscle
Why this is the answer
Ipratropium is an inhaled antimuscarinic. It blocks vagally mediated bronchoconstriction and mucus secretion, which is especially useful in COPD.
Answer
C · It blocks muscarinic receptors in airway smooth muscle
2.Pharmacology
Answer: C · Water intoxication from the antidiuretic effect of oxytocin
Why this is the answer
Oxytocin has antidiuretic activity at high doses. With large volumes of fluid this can cause water retention and dilutional hyponatraemia, so fluid balance and sodium are monitored.
Answer
C · Water intoxication from the antidiuretic effect of oxytocin
3.Dosage calculations
Answer: D = 600 mg
Dose calculation: the amount to give equals what is prescribed divided by what you have, times the quantity it comes in: amount = (desired dose/stock strength) × stock volume. Always keep the units the same (convert g to mg, mg to mcg first) and check that the answer is sensible.
Total per day
30·60 = 1800 mg
Per dose
D = 1800/3 = 600 mg
Answer
D = 600 mg
4.Dosage calculations
Answer: D = 349.1 mg
Body-surface-area dosing: many cytotoxic and some paediatric doses are prescribed per square metre of body surface area: dose (mg) = dose per m² × BSA (m²). The Mosteller formula estimates BSA = √(height (cm) × weight (kg)/3600).
Body surface area
BSA = √(156·45/3600) = √1.95 = 1.396 m²
Dose
D = 250·1.396 = 349.1 mg
Answer
D = 349.1 mg
5.Clinical pharmacokinetics
Answer: R = 22.68 mg/h
Clearance and volume: at steady state the dosing rate equals the elimination rate, so the maintenance rate = CL × Css. A loading dose is LD = Vd × C/(S × F), with S the salt factor (fraction of active drug in the salt) and F the bioavailability (1 for IV). From two levels, k = ln(C₁/C₂)/Δt; for an IV bolus Vd = dose/C₀ and CL = k × Vd. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Clearance
CL = 0.03·63 = 1.89 L/h
Infusion rate
R = 1.89·12 = 22.68 mg/h
Answer
R = 22.68 mg/h
6.Clinical pharmacokinetics
Answer: τ = 10 h
Designing a regimen: with rapid IV doses the level falls from peak to trough during the interval, so τ = ln(Cpeak/Ctrough)/k and the dose that restores the peak is Vd × (Cpeak − Ctrough). The average steady-state level is Css,avg = S·F·dose/(CL·τ). An infusion rises as C = (R/CL)(1 − e−kt). For a drug cleared by the kidneys, the dose is scaled with the creatinine clearance. The numbers are for practice only; at the bedside always follow local protocols and have high-risk doses double-checked.
Rate constant
k = 0.693/2.5 = 0.2773 h⁻¹
Dosing interval
τ = ln(8/0.5)/0.2773 = 2.773/0.2773 = 10 h
Answer
τ = 10 h
In practice the interval is rounded to a convenient value such as 8, 12, 24 or 36 h, and the levels are checked again.